FDA Finds Consumers Continue to Buy Potentially Risky Drugs Over the Internet
Practice Puts Consumers at Risk and May Be More Expensive than Domestic Purchasing
ROCKVILLE, Md., July 2, 2007-The U.S. Food and Drug Administration continues to warn the American public about the dangers of buying medications over the Internet.
New data collected by the FDA show that consumers who are trying to save money on prescription drugs don’t need to take chances by buying prescription drugs from foreign Internet sites, because low-cost generic versions are available in the United States. This finding also may be an indication that some consumers are likely buying foreign drugs this way to avoid getting a prescription from their doctor or health care professional, since many Web sites do not require a prescription.
Safety Concerns
The use of prescription drugs without a prescription is an intrinsically unsafe practice. FDA urges consumers to have a prescription from their doctor or other health care professional before using prescription drugs. The agency also urges consumers to review www.fda.gov for important information before making such purchases.
Consumers should be aware of safety concerns of drugs purchased
from unregulated Internet sellers since some of these drugs
might:
require careful dosing and monitoring; not have adequate labeling
for safe use; be inappropriately packaged, therefore product
integrity is uncertain; have been withdrawn from the U.S. market
for safety or efficacy reasons; may carry risks that require
initial screening and/or periodic patient monitoring; cause
harm—such as a controlled substance (narcotic), whose use
should be supervised by a doctor or health care professional due to
abuse potential; and have clinically significant drug-drug
interactions.
Recent examinations of a sample of drugs shipped to U.S. consumers found several drugs are associated with higher risks and are more dangerous to the consumer if used without the supervision of a doctor or health care professional. For example, warfarin (an anticoagulant or blood thinner) is a medication that requires very close monitoring to prevent stroke or death. Another example is amoxicillin and other antibiotics that should not be used for self treatment to reduce the risk of antibiotic-resistant infections. Levothyroxine, a thyroid replacement hormone, also requires close monitoring to ensure effective treatment. Another blood thinner, clopidogrel, may pose increased risk of cardiac events, such as heart attack if used in sub-optimal doses, which might be found in imported tablets. (See more examples in Table 2).
Consumers are also at risk if the drugs are not properly labeled for safe and effective use. For example, alendronate sodium, which is used to treat and prevent osteoporosis, should include information warning patients of significant side effects if it is not taken appropriately. Imported eye drop preparations may not have been manufactured under proper conditions to ensure sterility, leaving patients susceptible to contamination that may result in serious infections. These are only a few examples demonstrating the importance of obtaining FDA-approved drugs and health care provider monitoring.
Cost Concerns
The examination of foreign mail shipments also found that about 45 percent of the imported products already are available in the United States as an FDA-approved generic drug (see Table 1). About half of these generic drugs are available through national pharmacy chain programs that offer generic prescriptions at a cost of $4 each. This cost is usually significantly less than the cost of drugs charged by Internet sellers.
FDA has documented problems with imported drug products and has taken action when possible against foreign Web sites selling counterfeit products. Some examples follow.
FDA Updates its Nationwide Alert on Counterfeit Blood Glucose Test Strips (October 23, 2006)www.fda.gov/bbs/topics/NEWS/2006/NEW01497.html
FDA Warns Consumers Not to Buy or Use Prescription Drugs from Various Canadian Websites that Apparently Sell Counterfeit Products (August 30, 2006)
www.fda.gov/bbs/topics/NEWS/2006/NEW01441.html
Federal Authorities Cease Sale and Distribution of Counterfeit Lipitor (August 31, 2005)
www.fda.gov/bbs/topics/news/2005/new01228.html
FDA Takes Action Against Company for Illegal Importation of Unapproved, Potentially Unsafe Drugs (December 01, 2004)
www.fda.gov/bbs/topics/news/2004/NEW01142.html
FDA Warns Consumers About Counterfeit Drugs Purchased in Mexico (July 30, 2004)
www.fda.gov/bbs/topics/ANSWERS/2004/ANS01303.html
FDA Test Results of Prescription Drugs from Bogus Canadian Website Show All Products Are Fake and Substandard (July 13, 2004)
www.fda.gov/bbs/topics/news/2004/NEW01087.html
FDA Takes Action Against Foreign Websites Selling Counterfeit Contraceptive Patches (February 12, 2004)
www.fda.gov/bbs/topics/NEWS/2004/NEW01023.html
FDA and Johnson & Johnson Warn Public About Counterfeit Contraceptive Patches Sold Through Foreign Internet Site (February 04, 2004)
www.fda.gov/bbs/topics/NEWS/2004/NEW01017.html
FDA/U.S. Customs Import Blitz Exams Reveal Hundreds of Potentially Dangerous Imported Drug Shipments (September 29, 2003)
www.fda.gov/bbs/topics/NEWS/2003/NEW00948.html
|
TABLE 1: Examples of intercepted drugs available as |
|
|
Drug Product |
Common Intended Medical Use |
|---|---|
|
Amoxicillin Capsules |
Antibiotic |
|
Atenolol Tablets |
High blood pressure |
|
Fluoxetine Capsule |
Depression |
|
Hydrochlorothiazide (HCTZ) Tablets |
High blood pressure (diuretic) |
|
Isotretinoin Capsules |
Oral anti-acne |
|
Levothyroxine Tablets |
Thyroid hormone replacement |
|
Lisinopril Tablets |
High blood pressure |
|
Meloxicam Tablets |
Inflammation |
|
Metformin Tablets |
Diabetes (blood sugar levels) |
|
Metoprolol Tartrate Tablets |
High blood pressure |
|
Methotrexate Tablets |
Anti-cancer |
|
Nifedipine ER (extended release) Tablets |
High blood pressure |
|
Paroxetine Tablets |
Depression |
|
Phenytoin Capsules |
Anti-seizure |
|
Prednisone Tablets |
Inflammation (steroid) |
|
Simvastatin Tablets |
High cholesterol |
|
Tamoxifen Tablets |
Anti-cancer |
|
Warfarin Tablets |
Blood thinner |
|
TABLE 2: Examples of intercepted drugs with particular associated risks |
|
|
Drug Product |
Common Intended Medical Use |
|---|---|
|
Alendronate sodium Tablets |
Osteoporosis |
|
Amoxicillin Capsules |
Antibiotic |
|
Celecoxib Capsules |
Osteo- and Rheumatoid Arthritis |
|
Clopidogrel Tablets |
Blood thinner |
|
Isotretinoin Capsules |
Oral anti-acne |
|
Levothyroxine Tablets |
Thyroid hormone replacement |
|
Methotrexate Tablets |
Anti-cancer |
|
Prednisone Tablets |
Inflammation (steroid) |
|
Phenytoin Capsules |
Anti-seizure |
|
Warfarin Tablets |
Blood thinner |
|
Zolpidem Tablets |
Insomnia |
Media Inquiries:
Catherine McDermot, 301-827-6242
Consumer Inquiries:
888-INFO-FDA
Pharma Industry News Archive
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec
